ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study

Prats-Uribe, Albert; Sena, Anthony G.; Lai, Lana Yin Hui; Ahmed, Waheed-Ul-Rahman; Alghoul, Heba; Alser, Osaid; Alshammari, Thamir M.; Areia, Carlos; Carter, William; Casajust, Paula; Dawoud, Dalia; Golozar, Asieh; Jonnagaddala, Jitendra; Mehta, Paras P.; Gong, Mengchun; Morales, Daniel R.; Nyberg, Fredrik; Posada, Jose D.; Recalde, Martina; Roel, Elena; Shah, Karishma; Shah, Nigam H.; Schilling, Lisa M.; Subbian, Vignesh; Vizcaya, David; Zhang, Lin; Zhang, Ying; Zhu, Hong; Liu, Li东北大学; 南方医科大学; 河北医科大学; 中国医学科学院; 中国医学科学院北京协和医院
BRITISH MEDICAL JOURNAL2021-5-11DOI: 10.1136/bmj.n1038
37被引7阅读
引用收藏
分享

摘要

OBJECTIVE To investigate the use of repurposed and adjuvant drugs in patients admitted to hospital with covid-19 across three continents. @@@ DESIGN Multinational network cohort study. @@@ SETTING Hospital electronic health records from the United States, Spain, and China, and nationwide claims data from South Korea. @@@ PARTICIPANTS 303 264 patients admitted to hospital with covid-19 from January 2020 to December 2020. @@@ MAIN OUTCOME MEASURES Prescriptions or dispensations of any drug on or 30 days after the date of hospital admission for covid-19. @@@ RESULTS Of the 303 264 patients included, 290 131 were from the US, 7599 from South Korea, 5230 from Spain, and 304 from China. 3455 drugs were identified. Common repurposed drugs were hydroxychloroquine (used in from <5 (<2%) patients in China to 2165 (85.1%) in Spain), azithromycin (from 15 (4.9%) in China to 1473 (57.9%) in Spain), combined lopinavir and ritonavir (from 156 (<2%) in the VA-OMOP US to 2,652 (34.9%) in South Korea and 1285 (50.5%) in Spain), and umifenovir (0% in the US, South Korea, and Spain and 238 (78.3%) in China). Use of adjunctive drugs varied greatly, with the five most used treatments being enoxaparin, fluoroquinolones, ceftriaxone, vitamin D, and corticosteroids. Hydroxychloroquine use increased rapidly from March to April 2020 but declined steeply in May to June and remained low for the rest of the year. The use of dexamethasone and corticosteroids increased steadily during 2020. @@@ CONCLUSIONS Multiple drugs were used in the first few months of the covid-19 pandemic, with substantial geographical and temporal variation. Hydroxychloroquine, azithromycin, lopinavir-ritonavir, and umifenovir (in China only) were the most prescribed repurposed drugs. Antithrombotics, antibiotics, H2 receptor antagonists, and corticosteroids were often used as adjunctive treatments. Research is needed on the comparative risk and benefit of these treatments in the management of covid-19.

相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
BRITISH MEDICAL JOURNAL
发表日期
2021-05-11
卷期
第 373 卷
页码
n1038
DOI
10.1136/bmj.n1038
成果收录
SCIE

作者

  • P

    Prats-Uribe, Albert (第一作者)

  • S

    Sena, Anthony G.

查看全部 43 位作者收起作者
  • L

    Lai, Lana Yin Hui

  • A

    Ahmed, Waheed-Ul-Rahman

  • A

    Alghoul, Heba

  • A

    Alser, Osaid

  • A

    Alshammari, Thamir M.

  • A

    Areia, Carlos

  • C

    Carter, William

  • C

    Casajust, Paula

  • D

    Dawoud, Dalia

  • G

    Golozar, Asieh

  • J

    Jonnagaddala, Jitendra

  • M

    Mehta, Paras P.

  • G

    Gong, Mengchun

  • M

    Morales, Daniel R.

  • N

    Nyberg, Fredrik

    inst med

  • P

    Posada, Jose D.

  • R

    Recalde, Martina

  • R

    Roel, Elena

  • S

    Shah, Karishma

  • S

    Shah, Nigam H.

  • S

    Schilling, Lisa M.

  • S

    Subbian, Vignesh

  • V

    Vizcaya, David

  • Z

    Zhang, Lin

    chinese acad med sci · peking union med coll

  • Z

    Zhang, Ying

  • Z

    Zhu, Hong

    southern med univ

  • L

    Liu, Li

    southern med univ

  • C

    Cho, Jaehyeong

  • L

    Lynch, Kristine E.

  • M

    Matheny, Michael E.

  • Y

    You, Seng Chan

  • R

    Rijnbeek, Peter R.

  • H

    Hripcsak, George

  • L

    Lane, Jennifer C. E.

  • B

    Burn, Edward

  • R

    Reich, Christian

  • S

    Suchard, Marc A.

  • D

    Duarte-Salles, Talita

  • K

    Kostka, Kristin

  • R

    Ryan, Patrick B.

  • P

    Prieto-Alhambra, Daniel

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417